Targazyme
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2100 Palomar Airport Rd Ste 214-19, Carl...Phone Number
(760) 448-1168Website
www.targazyme.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About Targazyme
TargaZyme is focused on developing next-generation enzyme biopharmaceuticals aimed at treating serious auto-immune, neurodegenerative diseases, and cancer. Their mission is to enable precise delivery of therapeutic cells to diseased tissues, enhancing therapeutic potency and residence time. The company boasts a strong portfolio with over 35 worldwide patents and significant funding, positioning itself as a leader in the biopharma industry. TargaZyme has received numerous accolades, including recognition as one of the top innovative biopharma companies in 2023.Explore more
Targazyme Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Targazyme your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Targazyme recently announced quarterly report
Check if Targazyme has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Targazyme launches new products
Targazyme, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Targazyme is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Targazyme
Funding: Get notified immidiatlly once Targazyme has new funding data
Click to see if Targazyme had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Targazyme
Compare insights from companies similar to Targazyme, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Targazyme is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Targazyme is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Targazyme.
Targazyme financials insights
Gather financial insights about Targazyme, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
Targazyme Tech Stack
A closer look at the technologies used by Targazyme
See more technologies
Targazyme News & Media
Targazyme Appoints Jim Caggiano as CEO
CARLSBAD, Calif., Sept. 11, 2020 /PRNewswire/ -- Targazyme Inc., a late clinical-stage biopharmaceutical company developing novel fucosyltransferase enzyme technologies and products to improve clinical efficacy, safety, and cost of care outcomes for immuno-oncology and stem cell...Award Received from the Sexual Medicine Society of North America to Fund a Targazyme TZ101 Study to Reverse Erectile Dysfunction in Prostate Cancer Patients
SAN DIEGO, CA / ACCESSWIRE / March 6, 2019 / Targazyme, a clinical-stage biopharmaceutical company developing novel enzyme products to improve efficacy outcomes for stem cell transplantation, immunotherapy, gene therapy and regenerative medicine, announced today an award from The Sexual Medicine Society of North America. This award will fund a pivotal study at The University of Texas Health Science Center to prove the concept that TZ 101 treated mesenchymal stem cells reverses erectile dysfuncti
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Targazyme
Sign Up For FreeTo access detailed company insights
TargaZyme is focused on developing next-generation enzyme biopharmaceuticals aimed at treating serious auto-immune, neurodegenerative diseases, and cancer. Their mission is to enable precise delivery of therapeutic cells to diseased tissues, enhancing therapeutic potency and residence time. The company boasts a strong portfolio with over 35 worldwi... Read More
